Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync

BACKGROUND AND OBJECTIVES: Carbapenem treatment for Acinetobacter baumannii infections presently faces threats owing to the production of several types of carbapenemase enzymes, prevalence of which varies among different countries. We explored the current trend of antibiotic resistance in A. baumann...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahhabi, Abolfazl, Hasani, Alka, Rezaee, Mohammad Ahangarzadeh, Baradaran, Behzad, Hasani, Akbar, Kafil, Hossein Samadi, Soltani, Elgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416588/
https://www.ncbi.nlm.nih.gov/pubmed/34540166
http://dx.doi.org/10.18502/ijm.v13i3.6388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416588/
https://www.ncbi.nlm.nih.gov/pubmed/34540166
http://dx.doi.org/10.18502/ijm.v13i3.6388

Ejemplares similares